Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

NCT03117751 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

790

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia
Acute Lymphoblastic Lymphoma

Interventions

DRUG: Prednisone
DRUG: Vincristine
DRUG: Daunorubicin
DRUG: Pegaspargase
DRUG: Erwinase®
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Mercaptopurine
DRUG: Dasatinib
DRUG: Methotrexate
DRUG: Blinatumomab
DRUG: Ruxolitinib
DRUG: Bortezomib
DRUG: Dexamethasone
DRUG: Doxorubicin
DRUG: Etoposide
DRUG: Clofarabine
DRUG: Vorinostat
DRUG: Idarubicin
DRUG: Nelarabine

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]
[object Object]
[object Object]